Research progress on positron emission tomography using radionuclide-labeled fibroblast activation protein inhibitor in diagnosis of cardiac diseases

Research progress on positron emission tomography using radionuclide-labeled fibroblast activation protein inhibitor in diagnosis of cardiac diseases

Fibroblast activation protein (FAP) is a type Ⅱ transmembrane serine protease specifically expressed on the surface of activated cardiac fibroblasts (CFs). During myocardial injury, inflammation, and fibrosis, it drives myocardial interstitial remodeling and collagen deposition by degrading the extr...

Full description

Saved in:

Bibliographic Details
Main Author:	JIA Yingqi, ZHANG Min, LI Biao
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2025-04-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|fibroblast activation protein\|myocardial fibrosis\|myocardial injury\|ventricular remodeling\|extracellular matrix
Online Access:	https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188877346-1457288638.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myocardial remodeling and fibroblast growth factor in patients with resistant hypertension
by: M. S. Litvinova, et al.
Published: (2022-12-01)

Neutrophil extracellular traps aggravate uremic cardiomyopathy by inducing myocardial fibroblast pyroptosis
by: Ying Xu, et al.
Published: (2025-05-01)

FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
by: Sonia Zaghdoudi, et al.
Published: (2020-10-01)

Effects of SGLT2 inhibitors on cardiac autonomic activity and ventricular remodeling in patients with acute myocardial infarction: study protocol for a clinical trial
by: Jun Wan, et al.
Published: (2025-07-01)

Tcf21 modulates fibroblast activation and promotes cardiac fibrosis after injury via Pdgfrb signaling
by: Yusuke Baba, et al.
Published: (2025-08-01)

Follistatin‐like 1 promotes cardiac fibroblast activation and protects the heart from rupture
by: Sonomi Maruyama, et al.
Published: (2016-05-01)

Association of left ventricular structural remodeling types with fibronectin deficiency in patients with multivessel coronary artery disease
by: A. R. Mingalimova, et al.
Published: (2023-12-01)

Cardiac troponin T in coronary heart disease patients with chronic heart failure
by: V. S. Nikiforov, et al.
Published: (2005-02-01)

Bibliometric analysis of MXRA7 gene research trajectory: trends and insights (2015–2024)
by: Huihui Zhang, et al.
Published: (2025-06-01)

IMPORTANCE OF CARDIAC AND PULMONARY HEMODYNAMICAL VALUES IN VARIOUS PERIODS OF MYOCARDIAL INFARCTION FOR EARLY DIAGNOSING POSTINFARCTIONAL HEART REMODELING
by: N. I. Tarasov, et al.
Published: (2001-02-01)

The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets
by: Xiufeng Wang, et al.
Published: (2025-08-01)

Overweight and early heart remodelling in women with arterial hypertension
by: E. M. Khurs, et al.
Published: (2010-04-01)

Application of 68Ga‐ and 177Lu‐Labeled FAP Inhibitor in Evaluation and Treatment of Cardiac Fibrosis After Myocardial Infarction
by: Yiheng Zhao, et al.
Published: (2025-06-01)

MMP14 as a central mediator of TGF-β1−induced extracellular matrix remodeling in graves’ orbitopathy
by: Xing Wang, et al.
Published: (2025-07-01)

Effects of intensive rosuvastatin on ventricular remodeling and cardiac function in elderly patients with STEMI undergoing PCI
by: Yiran Qin, et al.
Published: (2025-08-01)

Role of Speckle Tracking in the Evaluation of Left Ventricular Remodeling After Streptokinase Infusion in Patients with Acute Anterior Myocardial Infarction
by: Sh. I. Farag, et al.
Published: (2020-12-01)

Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseases
by: Nicholas Black, et al.
Published: (2025-06-01)

Decoding mechanosensitive genes in cardiac fibroblasts via 3D hydrogel models of fibrosis
by: Heng Chen, et al.
Published: (2025-08-01)

The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary system
by: Ri Hong, et al.
Published: (2025-04-01)

Enhanced THBS2 promotes collagen synthesis and inflammatory secretome of fibroblasts in idiopathic pulmonary fibrosis
by: Lu Yu, et al.
Published: (2025-07-01)

Benefits of adding coronary calcium score scan to stress myocardial perfusion positron emission tomography imaging
by: Ahmed Fathala, et al.
Published: (2019-01-01)

The Role of Fibroblasts in Dystrophic Epidermolysis Bullosa Pathogenesis and Current Treatment Approaches
by: Alexander Nyström, et al.
Published: (2025-05-01)

Left ventricular remodeling in patients with right ventricular myocardial infarction
by: M. T. Beyshenkulov,, et al.
Published: (2015-12-01)

THE LEVEL OF ADROPIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND PAROXYSMAL ATRIAL FIBRILLATION
by: Nataliia K. Pokrovska, et al.
Published: (2025-04-01)

Predictive factors of early left ventricular remodeling and reverse remodeling in patients with STEMI after successful reperfusion therapy
by: Yanbo Wang, et al.
Published: (2025-09-01)

Role of magnetic resonance imaging in the detection of myocardial fibrosis in life-threatening ventricular arrhythmias
by: V. E. Oleinikov, et al.
Published: (2023-08-01)

Redistribution of Perfusion and Myocardial Function in Patients With Multivessel Disease and Myocardial Infarction With ST Segment Elevation After Recanalization of an Infarct-Associated Artery According to the Results of Single Photon Emission Computed Tomography, Synchronized With Electrocardiography
by: I. M. Kuzmina, et al.
Published: (2023-02-01)

Clinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance
by: Anthony V. Pensa, et al.
Published: (2024-08-01)

Cardiac strain in right ventricular myocardial infarction and pulmonary embolism
by: E. S. Mazur, et al.
Published: (2020-03-01)

Sex-Specific Patterns and Predictors of Reverse Left Ventricular Remodeling and Outcomes in STEMI Patients with LVEF ≤ 50% After Successful Primary Angioplasty
by: Bogdan-Flaviu Buz, et al.
Published: (2025-07-01)

THE EFFECT OF COMBINED ANTIHYPERTENSIVE THERAPY ON THE BASIC PARAMETERS OF THE LEFT VENTRICLE MYOCARDIUM STRUCTURE AND FUNCTION IN WOMEN WITH METABOLIC SYNDROME AND HYPOTHYROIDISM
by: V. V. Skibitskiy, et al.
Published: (2015-12-01)

Pharmaceutical therapy programme for remodeling heart prevention after Q-wave myocardial infarction
by: R. M. Gafurova, et al.
Published: (2007-02-01)

The influence of renal anemia on cardiac remodelling in chronic glomerulonephritis
by: I. T. Murkamilov, et al.
Published: (2016-10-01)

The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience
by: А. О. Shevchenko, et al.
Published: (2019-01-01)

The role of Genipin crosslinked extracellular matrix loaded bFGF in the repair of peripheral nerve injury
by: Yijia Zhang, et al.
Published: (2025-07-01)

Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis
by: Linghui Zou, et al.
Published: (2025-04-01)

Myocardial fibrosis — a new component of heart remodeling in athletes?
by: A. S. Sharykin, et al.
Published: (2019-12-01)

Camellia sinensis powder rich in epicatechin and polyphenols attenuates isoprenaline induced cardiac injury by activating the Nrf2 HO1 antioxidant pathway in rats
by: Mirza Alimullah, et al.
Published: (2025-07-01)

A comparison between quantitative gated myocardial perfusion scintigraphy and strain echocardiography as indicators of ventricular functions in patients with anterior myocardial infarction
by: Seyhan Karacavus, et al.
Published: (2014-07-01)

Myocardial revascularization results: electrical, structural, and geometric left ventricular remodelling in diastolic heart failure
by: I. P. Tatarchenko, et al.
Published: (1970-01-01)